Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Squaric acid dibutylester promotes hair growth by activating immune cells, especially macrophages.

Black patients with a specific type of hair loss have a much higher chance of lacking enough vitamin D.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

JAK inhibitors are effective for long-term management of alopecia areata.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

Baricitinib shows promise in treating severe hair loss.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

Alopecia may lower the risk of substance use disorder.

A KRT71 mutation in Hereford cattle in Uruguay causes thin, curly hair and scaly skin.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

PCE-DP brightens skin and promotes hair growth by enhancing cell growth and reducing melanin uptake.

Modern treatments can effectively regrow hair and improve life for people with alopecia areata.

HAIRCARECUBE TM (HCC) helps hair products work better by getting active ingredients deeper into the hair.

Curcuma aeruginosa extract lotion significantly reduces underarm hair growth.

Clobetasol propionate ointment can help some people with total hair loss regrow hair.